The PSM (on liver cirrhosis, impaired liver status, AST, ALT, creatinine, AFP, BCLC stage 0/A, and curative therapy) to compare post-SVR and viremic HCC patients yielded 140 pairs of post-SVR HCC and viremic HCC patients who were comparable in most characteristics. This evidence concerns the gene AFP and hepatocellular carcinoma.